|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Ocular Therapeutix, Inc (OCUL) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
36 |
|
|
|
Total
Direct Shares :
|
12,726,479 |
|
|
Total
Indirect Shares :
|
20,480,159 |
| |
%
Held by Insiders:
|
8.16% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Williams Leslie J. |
Director |
2025-06-11 |
51,433 |
|
0 |
| Meyers Steve Lawrence |
Officer |
2025-06-11 |
152,728 |
|
0 |
| Warden Charles M |
Director |
2025-06-11 |
86,464 |
2021-02-15 |
0 |
| Raines Merilee |
Director |
2025-06-11 |
46,933 |
2022-06-16 |
0 |
| Lindstrom Richard L Md |
Director |
2025-06-11 |
143,145 |
2025-06-11 |
43,559 |
| Hong Seung Suh |
Director |
2025-06-11 |
46,933 |
2022-06-16 |
0 |
| Graves Adrienne L |
Director |
2025-06-11 |
50,000 |
2023-07-10 |
0 |
| Saroj Namrata |
Officer |
2025-06-11 |
200,000 |
|
0 |
| Waheed Nadia |
Chief Medical Officer |
2025-06-02 |
206,805 |
2024-06-01 |
0 |
| Dugel Pravin |
See Remarks, Director |
2025-05-23 |
3,499,099 |
2024-02-22 |
0 |
| Nayak Sanjay |
Chief Strategy Officer |
2025-05-23 |
281,623 |
2024-02-22 |
0 |
| Kaiser Peter |
Chief Development Officer |
2025-05-23 |
207,104 |
2024-10-02 |
0 |
| Heier Jeffrey S. |
Chief Scientific Officer |
2025-05-23 |
262,974 |
2019-03-15 |
0 |
| Notman Donald |
See Remarks |
2025-02-11 |
308,444 |
2017-12-07 |
0 |
| Anderman Todd |
Chief Legal Officer |
2024-10-07 |
98,700 |
2024-10-07 |
0 |
| White Christopher G |
Chief Business Officer |
2024-02-05 |
123,689 |
2022-02-03 |
0 |
| Mattessich Antony C. |
President and CEO, Director |
2024-02-05 |
588,701 |
2024-02-05 |
6,500 |
| Ozden Rabia Gurses |
Chief Medical Officer |
2024-02-05 |
153,054 |
|
0 |
| Strassburger Philip C. |
General Counsel |
2024-02-05 |
161,493 |
2022-02-03 |
0 |
| Goldstein Michael H. |
President, Ophthalmology & CMO |
2022-02-03 |
313,335 |
2019-03-15 |
0 |
| Peacock Bruce |
Director |
2020-12-03 |
0 |
2020-12-03 |
0 |
| Sawhney Amarpreet |
Chairman of the Board, Director |
2019-06-07 |
1,056,031 |
2019-06-07 |
1,958,942 |
| Hanley Kevin F. |
See Remarks |
2018-12-14 |
20,000 |
2018-12-10 |
0 |
| Bollag Daniel M |
See Remarks |
2018-12-06 |
42,100 |
2017-12-06 |
0 |
| Fortune James |
Chief Operating Officer |
2015-09-15 |
112,060 |
|
0 |
| Versant Side Fund Iii, L.p. |
10% Owner |
2015-06-15 |
2,202,377 |
2015-06-15 |
13,007 |
| Sv Life Sciences Fund Iv Strategic Partners, L. P. |
10% Owner |
2015-06-10 |
61,084 |
2015-06-10 |
2,212,607 |
| Ankerud Eric |
See Remarks |
2014-07-30 |
78,651 |
|
0 |
| Ascension Health Ventures Ii, Llc |
10% Owner |
2014-07-30 |
2,100,138 |
2014-07-30 |
0 |
| Sv Life Sciences Fund Iv (gp), L.p. |
10% Owner |
2014-07-30 |
71,381 |
2014-07-30 |
2,585,607 |
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
2014-07-30 |
0 |
2015-02-02 |
19,588 |
| Hurley Charles Andrew |
|
|
0 |
|
0 |
| Summer Road Llc |
|
|
0 |
2024-02-26 |
8,591,401 |
| Talamo Jonathan H. |
|
|
0 |
|
0 |
| Opaleye Management Inc. |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
| Chadha Jaswinder |
Director |
|
0 |
2014-07-30 |
130,448 |
|
|
